Osteosarcoma is a type of bone cancer that originates in the cells that form an individual's bones. In rare cases, it may ...

Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care. While genetic ...

OS Therapies, Inc. (NYSE-A: OSTX) entered into agreements for the commercial manufacture of OST-HER2. The company is ...

A new review highlights SETDB1 as a key player in osteosarcoma, promoting tumor growth, immune evasion and therapy resistance ...

New research using data from the 100,000 Genomes Project has identified a genetic change that drives osteosarcoma, an ...

Primary bone cancer (that arises directly in the bone), is relatively rare. Different types of bone tissue give rise to different types of primary bone cancer: osteosarcoma develops from cells ...

Like most cancers, the risk of bone cancer increases with age. But for some types of bone cancer, younger people have a higher risk. Osteosarcoma is more common in adolescents (10 to 19 years). It ...

A new review was published in Oncotarget, Volume 16, on February 12, 2025, titled “SETDB1 amplification in osteosarcomas: ...

The company is currently organizing additional data about the recently completed treatment phase of its Phase 2b trial of OST-HER2 to prevent recurrence of lung metastatic osteosarcoma in ...